+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Efficient ArndtEistert Synthesis of Selective 5-Ht 7 Receptor Antagonist Sb-269970



Efficient ArndtEistert Synthesis of Selective 5-Ht 7 Receptor Antagonist Sb-269970



Synthetic Communications 39(18): 3243-3253




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 067288235

Download citation: RISBibTeXText

DOI: 10.1080/00397910902737155


Related references

Characterization of SB-269970-A, a selective 5-HT7 receptor antagonist. British Journal of Pharmacology 130(3): 539-548, 2000

Effects of the selective 5-HT(7) receptor antagonist SB-269970 in animal models of psychosis and cognition. Behavioural Brain Research 228(1): 211-218, 2012

Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression. Neuropharmacology 51(3): 578-586, 2006

Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats. European Journal of Pharmacology 553(1-3): 185-190, 2006

Behavioral profile of SB 269970, a selective 5-HT(7) serotonin receptor antagonist, in social encounters between male mice. Methods and Findings in Experimental and Clinical Pharmacology 26(7): 515-518, 2004

Effects of the selective 5-HT7 receptor antagonist SB-269970 and amisulpride on ketamine-induced schizophrenia-like deficits in rats. Plos One 8(6): E66695, 2014

Effects of the selective 5-HT7 receptor antagonist SB-269970 on premature responding in the five-choice serial reaction time test in rats. Behavioural Brain Research 289: 149-156, 2016

Efficient Synthesis Of A Selective Y5 Receptor Antagonist. Synthetic Communications 32(11): 1715-1719, 2002

Aging and SB-269970-A, a selective 5-HT7 receptor antagonist, attenuate circadian phase advances induced by microinjections of serotonergic drugs in the hamster dorsal raphe nucleus. Brain Research 1008(1): 40-48, 2004

SB-269970 A selective antagonist radioligand for 5-HT7 receptors. British Journal of Pharmacology 128(PROC SUPPL ): 233P, 1999

(3H)-SB-269970 - A selective antagonist radioligand for 5-HT7 receptors. British Journal of Pharmacology 130(2): 409-417, 2000

Selective functionalization of s tyrosine development of a highly efficient synthesis of fibrinogen receptor antagonist l 700462. Abstracts of Papers American Chemical Society 204(1-2): ORGN 271, 1992

SB-269970 is a potent and selective antagonist at human cloned and guinea-pig brain 5-HT7 receptors. British Journal of Pharmacology 128(PROC SUPPL ): 232P, 1999

A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970). Journal of Medicinal Chemistry 43(3): 342-345, 2000

Effects of the 5-HT7 receptor antagonist SB-269970 on rat hormonal and temperature responses to the 5-HT1A/7 receptor agonist 8-OH-DPAT. Neuroscience Letters 404(1-2): 122-126, 2006